secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2024-10-17T23:59:59+00:00
Accession:  0001493152-24-041443
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma closes $600K convertible note offering; CEO invests $237.5K
--------------------------------------------------------------------------

- Closed $600,000 of an up to $1.3 million senior secured convertible note and warrant offering.
- CEO Anatoly Dritschilo invested $237,500 in the offering.
- Notes carry 5% OID, 14.5% interest, 1-year term, convertible at 110% premium; prepayable at 107%.
- Warrants for 45% of conversion shares, exercisable at 125% of prior day's closing price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224041443/0001493152-24-041443-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224041443/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041443

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer